कृपया अन्य खोज का प्रयास करें
Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. Its products pipeline includes Budesolv for the treatment of allergic rhinitis and autoimmune gastritis; Tacrosolv, which is in Phase II clinical trial for anterior inflammatory eye diseases; Carravin for the treatment of nasal congestion; and Inhaleen that is in Phase I clinical trial for viral pneumonia, as well as Carragelose, which consists of nasal and throat sprays, and lozenges for treating viral respiratory infections. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Simon Nebel | 55 | 2017 | Independent Chairman of Supervisory Board |
Ulrich Kinzel | 59 | 2022 | Independent Member of Supervisory Board |
Eva Hofstadter-Thalmann | - | 2023 | Member of Supervisory Board |
Julian Crane | - | - | Member of Scientific Advisory Board |
Talin Barisani | - | - | Member of Scientific Advisory Board |
Elisabeth Lackner | 50 | 2022 | Independent Member of Supervisory Board |
Ron Eccles | - | - | Member of Scientific Advisory Board |
Balamurali Ambati | - | - | Member of Scientific Advisory Board |
Brigitte Ederer | 67 | 2018 | Independent Vice Chairwoman of the Supervisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है